Research | OneLook Acronym Finder |
Serial Number | 79068686 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Sughrue Mion, PLLC |
Attorney Name | Gary D. Krugman |
Law Office Assigned | M30 |
Employee Name | LAM, HAI-LY HUYNH |
2008-11-27 | Application Filed |
2011-01-18 | Abandon |
2011-02-14 | Location: TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED |
2011-02-14 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | Glycotope GmbH |
Entity Statement | Limited Liability Company |
Address | Robert-Rössle-Str. 10 13125 Berlin DE |
Legal Entity Type | |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering substances and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and related preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic reagents, other than for medical purposes, namely, for use in biochemistry, clinical chemistry and microbiology; carbohydrates used as an ingredient or as an integral component in food or nutraceuticals; cultures of microorganisms, other than for medical or veterinary use, and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms or cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of proteins and peptides; expression systems for proteins and peptides, particularly on the basis of cells, particularly human cells and microorganisms, namely, expression systems for engineered or glycosylated proteins or peptides, expression systems with optimized glycosylation activity; milk ferments for chemical purposes |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2009-06-11 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-06-12 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2009-06-12 | 3 DOCK D:Assigned to Examiner |
APPLICATION FILING RECEIPT MAILED | 2009-06-16 | 4 MAFR O:Outgoing Correspondence |
NON-FINAL ACTION WRITTEN | 2009-06-25 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2009-06-26 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2009-06-26 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2009-06-26 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2009-09-19 | 9 RFNT P: |
CORRECTION TRANSACTION RECEIVED FROM IB | 2009-10-09 | 10 CRCV M: |
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | 2009-10-21 | 11 CREV I:Incoming Correspondence |
ATTORNEY REVIEW COMPLETED | 2009-11-09 | 12 ATRV O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-12-22 | 13 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2010-01-06 | 14 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-01-06 | 15 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-01-06 | 16 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2010-03-13 | 17 CNFR R:Renewal |
FINAL REFUSAL MAILED | 2010-03-15 | 18 CNFR O:Outgoing Correspondence |
SUBSEQUENT FINAL REFUSAL WRITTEN | 2010-07-15 | 19 CFRC R:Renewal |
SUBSEQUENT FINAL MAILED | 2010-07-16 | 20 CFRC O:Outgoing Correspondence |
SUBSEQUENT FINAL MAILED | 2010-07-16 | 21 CFRC O:Outgoing Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2011-02-14 | 22 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2011-02-14 | 23 MAB2 O:Outgoing Correspondence |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2011-03-10 | 24 OPNR P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2011-03-10 | 25 OPNS P: |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2011-04-02 | 26 OPNX P: |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2012-02-14 | 27 FICR P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2012-02-14 | 28 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2012-03-08 | 29 FINT P: |
NEW REPRESENTATIVE AT IB RECEIVED | 2013-12-14 | 30 NREP P: |
INTERNATIONAL REGISTRATION RENEWED | 2018-12-13 | 31 RNWL P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.